By far the strongest genetic risk factor for Alzheimer’s disease is a variant of apolipoprotein E, or ApoE. People who carry ...

The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.

While physicians and scientists have long known Alzheimer's disease involves the buildup of toxic protein fragments in the ...

Scientists at Northwestern University say a common anti-seizure medication may be able to prevent the earliest steps of Alzheimer’s disease—long before memory loss begins. In a study published in ...

A cheap anti-seizure drug may help prevent the brain plaques linked to Alzheimer’s disease, new research suggests. Scientists ...

Studies reveal the therapeutic mechanism of action for levetiracetam to prevent the production of Aβ and, consequently, downstream irreversible damage.

Researchers engineered CD4+ chimeric antigen receptor T cells targeting fibrillar amyloid beta and tested them in a mouse ...

While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in ...

Experts have known for some time that Alzheimer’s disease involves the build-up of toxic protein fragments in the brain.

Scientists have found that the anti-seizure medication levetiracetam prevents the buildup of faulty amyloid-beta proteins in ...

Comprehensive residue-level mapping of amyloid-beta recognition reveals how sequence variants, post-translational ...